NIH-funded research R21 grant

Using monthly malaria pill visits to support children’s nutrition and health

Official title: Leveraging the seasonal malaria chemoprevention platform to address malaria and malnutrition

Funded at University of California, San Francisco · NIH-11240334 · Data updated 2026-11-12

This project adds nutrition and other child-health services to the monthly malaria drug visits for young children in Burkina Faso to help them stay healthier during the rainy season.

More Malaria research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startDecember 4, 2024
Project endNovember 30, 2026
Funding year2026
Award (this year)$161,212
NIH project number5R21AI182714-02
Project IDNIH-11240334 on NIH RePORTER

Who could benefit from this research

Could help

Young children aged 3 to 59 months (about 3 months to 5 years) who live in SMC-covered communities in the Sahel region of Burkina Faso are the intended participants.

Less likely to help

Older children, adults, children outside the target geographic area, or children with medical reasons that prevent them from receiving SP-AQ are unlikely to benefit from participating.

What this research studies

If your child joins, community health workers will come to homes each month to give the standard seasonal malaria medicines (SP-AQ) and also deliver extra supports such as nutrition screening, counseling, or supplements. The team will follow children aged 3 to 59 months through the high-risk rainy months to see how the combined services affect malaria illness and growth. Health workers will record illnesses, weight and other child-health measures during and after the season. The work is a pilot to see whether adding these services to the established malaria-delivery visits is practical and helpful for families.

Why it matters

Potential benefit: If successful, the approach could lower malaria cases and improve nutrition and growth for young children during the high-risk season.

How similar studies have gone: Seasonal malaria chemoprevention is already proven to cut clinical malaria in children, and prior work suggests antimalarial treatment can help weight gain, but combining SMC with nutrition co-interventions is a relatively new, pilot approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Oldenburg, Catherine Elizabeth — University of California, San Francisco
  • Study coordinator: Oldenburg, Catherine Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.